Decorin causes autophagy in endothelial cells via Peg3

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 28, 2013, Pages

  Buraschi, Simone ^a,b   Neill, Thomas ^a,b   Goyal, Atul ^a,b   Poluzzi, Chiara ^a,b   Smythies, James ^a,b   Owens, Rick T ^c   Schaefer, Liliana ^d   Torres, Annabel ^a,b   Iozzo, Renato V ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c LIFECELL CORPORATION   (United States)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Microvascular endothelial cells; Porcine aortic endothelial cells; Small leucine rich proteoglycan

Indexed keywords

BECLIN 1; BETA CATENIN; DECORIN; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN LIGHT CHAIN 3 ALPHA; PROTEOGLYCAN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BINDING AFFINITY; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROVASCULAR ENDOTHELIAL CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MORPHOGENESIS; PATERNALLY EXPRESSED GENE 3; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

MICROVASCULAR ENDOTHELIAL CELLS; PORCINE AORTIC ENDOTHELIAL CELLS; SMALL LEUCINE-RICH PROTEOGLYCAN;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELLS, CULTURED; DECORIN; ENDOTHELIUM, VASCULAR; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MEMBRANE PROTEINS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

SUS;

EID: 84879905523     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1305732110     Document Type: Article

References (61)

1. Bissell MJ, Hines WC (2011) Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17(3):320-329.
2. Iozzo RV, Goldoni S, Berendsen A, Young MF (2011) Extracellular Matrix: An Overview, ed Mecham RP (Springer, Berlin), pp 197-231.
3. Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction. J Biol Chem 283(31):21305-21309.
4. Iozzo RV, Schaefer L (2010) Proteoglycans in health and disease: Novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 277(19):3864-3875.
5. Schaefer L, Iozzo RV (2012) Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. Curr Opin Genet Dev 22(1):56-57.
6. Bolton K, et al. (2008) Decorin is a secreted protein associated with obesity and type 2 diabetes. Int J Obes (Lond) 32(7):1113-1121. (Pubitemid 351986197)
7. Merline R, et al. (2011) Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal 4(199):ra75.
8. Xu Y-Z, et al. (2012) Dynamic reduction of plasma decorin following ischemic stroke: A pilot study. Neurochem Res 37(9):1843-1848.
9. Wu I-C, et al. (2010) Plasma decorin predicts the presence of esophageal squamous cell carcinoma. Int J Cancer 127(9):2138-2146.
10. Goldoni S, et al. (2004) Biologically active decorin is a monomer in solution. J Biol Chem 279(8):6606- 6612.
11. Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I (1999) Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 274(8):4489-4492.
12. Goldoni S, et al. (2009) Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 185(4):743-754.
13. Iozzo RV, et al. (2011) Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem 286(40):34712-34721.
14. Baghy K, et al. (2013) Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis. FEBS J 280(10):2150-2164.
15. Morrione A, Neill T, Iozzo RV (2013) Dichotomy of decorin activity on the insulin-like growth factor-I system. FEBS J 280(10):2138-2149.
16. Neill T, Schaefer L, Iozzo RV (2012) Decorin: A guardian from the matrix. Am J Pathol 181(2):380-387.
17. Reed CC, Gauldie J, Iozzo RV (2002) Suppression of tumorigenicity by adenovirusmediated gene transfer of decorin. Oncogene 21(23):3688-3695. (Pubitemid 34620532)
18. Tralhão JG, et al. (2003) In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. FASEB J 17(3):464-466.
19. Reed CC, et al. (2005) Decorin prevents metastatic spreading of breast cancer. Oncogene 24(6):1104-1110. (Pubitemid 40313888)
20. Grant DS, et al. (2002) Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 21(31):4765-4777. (Pubitemid 34879452)
21. Goldoni S, et al. (2008) An antimetastatic role for decorin in breast cancer. Am J Pathol 173(3):844-855.
22. Buraschi S, et al. (2010) Decorin antagonizes Met receptor activity and down-regulates β-catenin and Myc levels. J Biol Chem 285(53):42075-42085.
23. Neill T, et al. (2012) Decorin antagonizes the angiogenic network: Concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem 287(8):5492-5506.
24. Buraschi S, et al. (2012) Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model. PLoS ONE 7(9):e45559.
25. Maegawa S, et al. (2001) Epigenetic silencing of PEG3 gene expression in human glioma cell lines. Mol Carcinog 31(1):1-9. (Pubitemid 32520662)
26. Feng W, et al. (2008) Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 112(7):1489-1502. (Pubitemid 351441161)
27. Kohda T, et al. (2001) Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line. Genes Cells 6(3):237-247. (Pubitemid 32273386)
28. Dowdy SC, et al. (2005) Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. Gynecol Oncol 99(1):126-134. (Pubitemid 41354593)
29. Zhai Y, et al. (2010) Loss of estrogen receptor 1 enhances cervical cancer invasion. Am J Pathol 177(2):884-895.
30. Gloss BS, et al. (2012) Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers. Cancer Lett 318(1):76-85.
31. Jiang X, et al. (2010) The imprinted gene PEG3 inhibits Wnt signaling and regulates glioma growth. J Biol Chem 285(11):8472-8480.
32. Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140(3):313-326.
33. Thurston TLM, Wandel MP, von Muhlinen N, Foeglein A, Randow F (2012) Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482(7385):414-418.
34. Sai J, Raman D, Liu Y, Wikswo J, Richmond A (2008) Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis. J Biol Chem 283(39):26538-26547.
35. 2+ exchanger (NCX3) knock-out mice display an impairment in hippocampal long-term potentiation and spatial learning and memory. J Neurosci 31(20):7312-7321.
36. Khan GA, Girish GV, Lala N, Di Guglielmo GM, Lala PK (2011) Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast. Mol Endocrinol 25(8):1431-1443.
37. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437(2):169-183.
38. Goyal A, et al. (2011) Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): A dual receptor antagonism. J Biol Chem 286(29):25947-25962.
39. Goyal A, et al. (2012) Endorepellin affects angiogenesis by antagonizing diverse VEGFR2- evoked signaling pathways: Transcriptional repression of HIF-1α and VEGFA and concurrent inhibition of NFAT1 activation. J Biol Chem 287:43543- 43556.
40. Fong TAT, et al. (1999) SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res 59(1):99-106. (Pubitemid 29062964)
41. Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C (2009) p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol 29(10):2594-2608.
42. Thiaville MM, et al. (2013) DNA-binding motif and target genes of the imprinted transcription factor PEG3. Gene 512(2):314-320.
43. Kirkin V, McEwan DG, Novak I, Dikic I (2009) A role for ubiquitin in selective autophagy. Mol Cell 34(3):259-269.
44. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′- tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197(1):40-45. (Pubitemid 23358874)
45. Mizushima N, Komatsu M (2011) Autophagy: Renovation of cells and tissues. Cell 147(4):728-741.
46. White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12(6):401-410.
47. Zoeller JJ, et al. (2009) A central role for decorin during vertebrate convergent extension. J Biol Chem 284(17):11728-11737.
48. Heisenberg C-P, et al. (2000) Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation. Nature 405(6782):76-81. (Pubitemid 30321818)
49. Hammerschmidt M, et al. (1996) Mutations affecting morphogenesis during gastrulation and tail formation in the zebrafish, Danio rerio. Development 123:143-151. (Pubitemid 27056743)
50. Ichii M, Frank MB, Iozzo RV, Kincade PW (2012) The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. Blood 119(7):1683-1692.
51. Schwarzkopf M, Coletti D, Sassoon D, Marazzi G (2006) Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev 20(24):3440- 3452.
52. Besson V, et al. (2011) PW1 gene/paternally expressed gene 3 (PW1/Peg3) identifies multiple adult stem and progenitor cell populations. Proc Natl Acad Sci USA 108(28):11470-11475.
53. Neill T, et al. (2013) Decorin induces rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rhoassociated coiled-coil containing protein kinase 1. FEBS J 280(10):2353-2368.
54. Goldoni S, Iozzo RV (2008) Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer 123(11):2473-2479.
55. Iozzo RV, Sanderson RD (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 15(5):1013-1031.
56. Iozzo RV, et al. (1999) Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci USA 96(6):3092- 3097.
57. Relaix F, et al. (2000) Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis. Proc Natl Acad Sci USA 97(5):2105-2110. (Pubitemid 30134029)
58. Deng Y, Wu X (2000) Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. Proc Natl Acad Sci USA 97(22):12050-12055.
59. Seidler DG, et al. (2006) Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 281(36):26408-26418. (Pubitemid 44401849)
60. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269(43):26988-26995. (Pubitemid 24332901)
61. Zhu J-X, et al. (2005) Decorin evokes protracted internalization and degradation of the EGF receptor via caveolar endocytosis. J Biol Chem 280:32468-32479. (Pubitemid 41361859)